Congenital myasthenic syndrome in Israel

Genetic and clinical characterization

Sharon Aharoni, Menachem Sadeh, Yehuda Shapira, Simon Edvardson, Muhannad Daana, Talia Dor-Wollman, Aviva Mimouni-Bloch, Ayelet Halevy, Rony Cohen, Liora Sagie, Zohar Argov, Malcolm Rabie, Ronen Spiegel, Ilana Chervinsky, Naama Orenstein, Andrew G Engel, Yoram Nevo

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The objective of the study was to evaluate the epidemiology of patients with congenital myasthenic syndrome (CMS) in Israel. Targeted mutation analysis was performed based on the clinical symptoms and electrophysiological findings for known CMS. Additional specific tests were performed in patients of Iranian and/or Iraqi Jewish origin. All medical records were reviewed and clinical data, genetic mutations and outcomes were recorded. Forty-five patients with genetic mutations in known CMS genes from 35 families were identified. Mutations in RAPSN were identified in 13 kinships in Israel. The most common mutation was c.-38A>G detected in 8 patients of Iranian and/or Iraqi Jewish origin. Four different recessive mutations in COLQ were identified in 11 kinships, 10 of which were of Muslim-Arab descent. Mutations in CHRNE were identified in 7 kinships. Less commonly detected mutations were in CHRND, CHAT, GFPT1 and DOK7. In conclusion, mutations in RAPSN and COLQ are the most common causes of CMS in our cohort. Specific mutations in COLQ, RAPSN, and CHRNE occur in specific ethnic populations and should be taken into account when the diagnosis of a CMS is suspected.

Original languageEnglish (US)
Pages (from-to)136-140
Number of pages5
JournalNeuromuscular Disorders
Volume27
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Congenital Myasthenic Syndromes
Israel
Mutation
Islam
Medical Records
Epidemiology

Keywords

  • CHRNE
  • COLQ
  • Congenital myasthenic syndrome (CMS)
  • Genetic mutations
  • RAPSN

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Neurology
  • Clinical Neurology
  • Genetics(clinical)

Cite this

Aharoni, S., Sadeh, M., Shapira, Y., Edvardson, S., Daana, M., Dor-Wollman, T., ... Nevo, Y. (2017). Congenital myasthenic syndrome in Israel: Genetic and clinical characterization. Neuromuscular Disorders, 27(2), 136-140. https://doi.org/10.1016/j.nmd.2016.11.014

Congenital myasthenic syndrome in Israel : Genetic and clinical characterization. / Aharoni, Sharon; Sadeh, Menachem; Shapira, Yehuda; Edvardson, Simon; Daana, Muhannad; Dor-Wollman, Talia; Mimouni-Bloch, Aviva; Halevy, Ayelet; Cohen, Rony; Sagie, Liora; Argov, Zohar; Rabie, Malcolm; Spiegel, Ronen; Chervinsky, Ilana; Orenstein, Naama; Engel, Andrew G; Nevo, Yoram.

In: Neuromuscular Disorders, Vol. 27, No. 2, 01.02.2017, p. 136-140.

Research output: Contribution to journalArticle

Aharoni, S, Sadeh, M, Shapira, Y, Edvardson, S, Daana, M, Dor-Wollman, T, Mimouni-Bloch, A, Halevy, A, Cohen, R, Sagie, L, Argov, Z, Rabie, M, Spiegel, R, Chervinsky, I, Orenstein, N, Engel, AG & Nevo, Y 2017, 'Congenital myasthenic syndrome in Israel: Genetic and clinical characterization', Neuromuscular Disorders, vol. 27, no. 2, pp. 136-140. https://doi.org/10.1016/j.nmd.2016.11.014
Aharoni S, Sadeh M, Shapira Y, Edvardson S, Daana M, Dor-Wollman T et al. Congenital myasthenic syndrome in Israel: Genetic and clinical characterization. Neuromuscular Disorders. 2017 Feb 1;27(2):136-140. https://doi.org/10.1016/j.nmd.2016.11.014
Aharoni, Sharon ; Sadeh, Menachem ; Shapira, Yehuda ; Edvardson, Simon ; Daana, Muhannad ; Dor-Wollman, Talia ; Mimouni-Bloch, Aviva ; Halevy, Ayelet ; Cohen, Rony ; Sagie, Liora ; Argov, Zohar ; Rabie, Malcolm ; Spiegel, Ronen ; Chervinsky, Ilana ; Orenstein, Naama ; Engel, Andrew G ; Nevo, Yoram. / Congenital myasthenic syndrome in Israel : Genetic and clinical characterization. In: Neuromuscular Disorders. 2017 ; Vol. 27, No. 2. pp. 136-140.
@article{7d4ecb05b8a64b3cbbaf8ce3f6f9534b,
title = "Congenital myasthenic syndrome in Israel: Genetic and clinical characterization",
abstract = "The objective of the study was to evaluate the epidemiology of patients with congenital myasthenic syndrome (CMS) in Israel. Targeted mutation analysis was performed based on the clinical symptoms and electrophysiological findings for known CMS. Additional specific tests were performed in patients of Iranian and/or Iraqi Jewish origin. All medical records were reviewed and clinical data, genetic mutations and outcomes were recorded. Forty-five patients with genetic mutations in known CMS genes from 35 families were identified. Mutations in RAPSN were identified in 13 kinships in Israel. The most common mutation was c.-38A>G detected in 8 patients of Iranian and/or Iraqi Jewish origin. Four different recessive mutations in COLQ were identified in 11 kinships, 10 of which were of Muslim-Arab descent. Mutations in CHRNE were identified in 7 kinships. Less commonly detected mutations were in CHRND, CHAT, GFPT1 and DOK7. In conclusion, mutations in RAPSN and COLQ are the most common causes of CMS in our cohort. Specific mutations in COLQ, RAPSN, and CHRNE occur in specific ethnic populations and should be taken into account when the diagnosis of a CMS is suspected.",
keywords = "CHRNE, COLQ, Congenital myasthenic syndrome (CMS), Genetic mutations, RAPSN",
author = "Sharon Aharoni and Menachem Sadeh and Yehuda Shapira and Simon Edvardson and Muhannad Daana and Talia Dor-Wollman and Aviva Mimouni-Bloch and Ayelet Halevy and Rony Cohen and Liora Sagie and Zohar Argov and Malcolm Rabie and Ronen Spiegel and Ilana Chervinsky and Naama Orenstein and Engel, {Andrew G} and Yoram Nevo",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.nmd.2016.11.014",
language = "English (US)",
volume = "27",
pages = "136--140",
journal = "Neuromuscular Disorders",
issn = "0960-8966",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Congenital myasthenic syndrome in Israel

T2 - Genetic and clinical characterization

AU - Aharoni, Sharon

AU - Sadeh, Menachem

AU - Shapira, Yehuda

AU - Edvardson, Simon

AU - Daana, Muhannad

AU - Dor-Wollman, Talia

AU - Mimouni-Bloch, Aviva

AU - Halevy, Ayelet

AU - Cohen, Rony

AU - Sagie, Liora

AU - Argov, Zohar

AU - Rabie, Malcolm

AU - Spiegel, Ronen

AU - Chervinsky, Ilana

AU - Orenstein, Naama

AU - Engel, Andrew G

AU - Nevo, Yoram

PY - 2017/2/1

Y1 - 2017/2/1

N2 - The objective of the study was to evaluate the epidemiology of patients with congenital myasthenic syndrome (CMS) in Israel. Targeted mutation analysis was performed based on the clinical symptoms and electrophysiological findings for known CMS. Additional specific tests were performed in patients of Iranian and/or Iraqi Jewish origin. All medical records were reviewed and clinical data, genetic mutations and outcomes were recorded. Forty-five patients with genetic mutations in known CMS genes from 35 families were identified. Mutations in RAPSN were identified in 13 kinships in Israel. The most common mutation was c.-38A>G detected in 8 patients of Iranian and/or Iraqi Jewish origin. Four different recessive mutations in COLQ were identified in 11 kinships, 10 of which were of Muslim-Arab descent. Mutations in CHRNE were identified in 7 kinships. Less commonly detected mutations were in CHRND, CHAT, GFPT1 and DOK7. In conclusion, mutations in RAPSN and COLQ are the most common causes of CMS in our cohort. Specific mutations in COLQ, RAPSN, and CHRNE occur in specific ethnic populations and should be taken into account when the diagnosis of a CMS is suspected.

AB - The objective of the study was to evaluate the epidemiology of patients with congenital myasthenic syndrome (CMS) in Israel. Targeted mutation analysis was performed based on the clinical symptoms and electrophysiological findings for known CMS. Additional specific tests were performed in patients of Iranian and/or Iraqi Jewish origin. All medical records were reviewed and clinical data, genetic mutations and outcomes were recorded. Forty-five patients with genetic mutations in known CMS genes from 35 families were identified. Mutations in RAPSN were identified in 13 kinships in Israel. The most common mutation was c.-38A>G detected in 8 patients of Iranian and/or Iraqi Jewish origin. Four different recessive mutations in COLQ were identified in 11 kinships, 10 of which were of Muslim-Arab descent. Mutations in CHRNE were identified in 7 kinships. Less commonly detected mutations were in CHRND, CHAT, GFPT1 and DOK7. In conclusion, mutations in RAPSN and COLQ are the most common causes of CMS in our cohort. Specific mutations in COLQ, RAPSN, and CHRNE occur in specific ethnic populations and should be taken into account when the diagnosis of a CMS is suspected.

KW - CHRNE

KW - COLQ

KW - Congenital myasthenic syndrome (CMS)

KW - Genetic mutations

KW - RAPSN

UR - http://www.scopus.com/inward/record.url?scp=85009382832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009382832&partnerID=8YFLogxK

U2 - 10.1016/j.nmd.2016.11.014

DO - 10.1016/j.nmd.2016.11.014

M3 - Article

VL - 27

SP - 136

EP - 140

JO - Neuromuscular Disorders

JF - Neuromuscular Disorders

SN - 0960-8966

IS - 2

ER -